FTSE 100 today: Stocks inch higher as markets eye Trump’s Beijing arrival

Markets are being driven by Trump’s Beijing trip, with the FTSE 100 up 0.72%, the DAX up 0.59%, and the CAC 40 up 0.25% as hopes rise for progress on trade and rare-earth export curbs. Offseting the risk-on tone are hotter-than-expected U.S. inflation data and ongoing Middle East conflict, which continues to threaten Strait of Hormuz shipping and oil flows. In the UK, Babcock flagged a £140 million charge on its Type 31 frigate contract, Savills warned of weaker advisory transactions, BP bought a 40% stake in Uzbekistan exploration blocks, and Vistry cut its first-half profit outlook and paused buybacks.

Analysis

The near-term market setup is less about the Beijing optics and more about whether policy friction eases enough to extend the current AI capex cycle. Huang’s presence materially lowers the probability of an abrupt export-control escalation, which is the real bull case for NVDA: not a dramatic reopening of China, but preservation of a large installed base and continued high-end node demand into the next upgrade cycle. The second-order winner is the broader semiconductor supply chain, especially equipment and advanced packaging names, because any détente that keeps the funnel open tends to support order visibility even if unit growth slows.

The bigger risk is that the trip produces headline progress without operational follow-through. That would create a classic “sell the news” dynamic in semis: China revenue expectations get de-risked briefly, but if the summit ends with only a truce extension and no substantive relaxation on restrictions, investors may rotate from multiple-expansion to cash-flow names within days. In that scenario, NVDA likely remains structurally strong, but the incremental upside gets capped while volatility rises as the market re-prices the probability of future policy shocks.

Macro-wise, the Middle East backdrop matters because higher oil and hotter inflation reduce the market’s tolerance for long-duration growth multiples. That means NVDA can outperform on idiosyncratic policy relief, but it becomes more vulnerable if Treasury yields re-accelerate or risk appetite fades. The contrarian read is that the market may be underestimating how quickly China can use rare-earth leverage to extract concessions, making this less a clean de-risking event and more a temporary bargaining window with asymmetric headline risk over the next 2-6 weeks.

Key Decisions for Investors

• Buy NVDA on any post-summit pullback over the next 1-2 sessions; use a 4-8 week horizon. Risk/reward favors a tactical long because policy downside is already known, while any sign of export-control easing or truce extension can re-rate the name quickly.
• Pair long NVDA / short SOXX downside hedge via puts if you want isolated event exposure. This captures company-specific resilience while limiting beta if the summit disappoints and semis sell off broadly.
• Add a call spread in NVDA expiring 6-10 weeks out rather than outright stock if you expect only modest policy relief. This is the better structure if the market gets a headline pop but follow-through remains uncertain.
• Avoid chasing small-cap AI hardware beneficiaries until there is confirmation of actual rule relaxation. Their multiples are more fragile than NVDA’s, and they are more exposed to a 'headline-only' outcome.
• If yields and oil continue to rise, rotate partial exposure from high-multiple semis into quality cash-flow tech. The macro regime is not friendly to indefinite multiple expansion, even if the China trip is constructive.